Uterine Endometrial Carcinoma: 10 Years' Experience with Long-Term Follow-Up at a Single Korean Institution

被引:8
作者
Lee, Eun-Ju [2 ,3 ]
Kim, Tae-Joong
Choi, Chel Hun
Lee, Jeong-Won
Lee, Je-Ho
Bae, Duk-Soo
Park, Hyoung Moo [2 ,3 ]
Kim, Byoung-Gie [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul 135710, South Korea
[2] Chung Ang Univ, Sch Med, Dept Obstet, Seoul 156756, South Korea
[3] Chung Ang Univ, Sch Med, Dept Gynecol, Seoul 156756, South Korea
关键词
Endometrial cancer; Korean; Prognostic factor; GYNECOLOGIC CANCER; STAGE; SURVIVAL; LYMPHADENECTOMY; RISK; CELL; AGE;
D O I
10.1159/000338996
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To evaluate prognostic factors in Korean patients with endometrial cancer. Methods: A retrospective analysis was conducted on 248 patients who were staged surgically at the Samsung Medical Center between 1995 and 2004. Survival data were analyzed using Kaplan-Meier estimates, and multivariate analysis was performed using the Cox regression method. Results: The median age was 51 years (range 2175), which was younger than in previous studies in Western patients, and the age of 50 years was the cutoff to predict survival. More than half (55.6%) were normal weight or underweight (BMI <25). Multivariate analysis revealed that age, Federation Internationale de Gynecologie et d'Obstetrique (FIGO) stage, and histopathology were independent predictors of disease-free survival, and FIGO stage and p53 mutation were independent prognostic factors for disease-specific survival (DSS). The 5-year DSS for patients with stage I, II, III and IV disease was 95.6, 93.8, 69.8 and 50%, respectively. The 5-year DSS rate for patients with a p53 mutation was 84.4%, compared with 97.1% for patients without. Conclusions: Korean patients with endometrial cancer were younger and had a lower BMI than previously reported. Furthermore, age greater than 50 years was predictive of a poor outcome. Age, FIGO stage, histopathology and a p53 mutation were independent prognostic factors for survival. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:313 / 319
页数:7
相关论文
共 32 条
[1]   Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer? [J].
Alektiar, KM ;
McKee, A ;
Lin, O ;
Venkatraman, E ;
Zelefsky, MJ ;
McKee, B ;
Hoskins, WJ ;
Barakat, RR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (01) :79-85
[2]   Endometrial cancer [J].
Amant, F ;
Moerman, P ;
Neven, P ;
Timmerman, D ;
Van Limbergen, E ;
Vergote, I .
LANCET, 2005, 366 (9484) :491-505
[3]   Current issues in the management of endometrial cancer [J].
Bakkum-Gamez, Jamie N. ;
Gonzalez-Bosquet, Jesus ;
Laack, Nadia N. ;
Mariani, Andrea ;
Dowdy, Sean C. .
MAYO CLINIC PROCEEDINGS, 2008, 83 (01) :97-112
[4]   Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[5]   Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer [J].
Cragun, JM ;
Havrilesky, LJ ;
Calingaert, B ;
Synan, I ;
Secord, AA ;
Soper, JT ;
Clarke-Pearson, DL ;
Berchuck, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3668-3675
[6]   Carcinoma of the corpus uteri [J].
Creasman, W. T. ;
Odicino, F. ;
Maisonneuve, P. ;
Quinn, M. A. ;
Beller, U. ;
Benedet, J. L. ;
Heintz, A. P. M. ;
Ngan, H. Y. S. ;
Pecorelli, S. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 :S105-S143
[7]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[8]  
2-8
[9]   Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium [J].
Creasman, WT ;
Kohler, MF ;
Odicino, F ;
Maisonneuve, P ;
Boyle, P .
GYNECOLOGIC ONCOLOGY, 2004, 95 (03) :593-596
[10]  
CREASMAN WT, 1990, OBSTET GYNECOL, V75, P287